Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2009
02/26/2009WO2008153968A3 Inkjet gene printing
02/26/2009WO2008153731A4 Processes for improved strain engineering
02/26/2009WO2008153446A3 Method for amplifying specific nucleic acid fragments with the aid of a recurrent chain reaction
02/26/2009WO2008152652A3 A dengue envelope domain iii-based tetravalent protein vaccine
02/26/2009WO2008152262A3 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system
02/26/2009WO2008151440A4 Modifying glycoprotein production in plants
02/26/2009WO2008151307A9 T-cell cytokine-inducing surface molecules and methods of use
02/26/2009WO2008151182A3 Herpes simplex virus amplicon vectors derived from primary isolates
02/26/2009WO2008142364A3 Rhd6 and its use in modulating plant root hair development
02/26/2009WO2008142163A3 Plants having enhanced yield-related traits and a method for making the same
02/26/2009WO2008137985A3 Methods for inducing cotton embryogenic callus
02/26/2009WO2008136848A3 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease
02/26/2009WO2008127296A3 Methods and compositions for treating tularemia
02/26/2009WO2008125972A3 Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
02/26/2009WO2008110914A3 Methods for producing active scfv antibodies and libraries therefor
02/26/2009WO2008109548A3 Nucleic acid compounds for inhibiting tgfb gene expression and uses thereof
02/26/2009WO2008109472A9 Nucleic acid compounds for inhibiting pcsk9 gene exprression and uses thereof
02/26/2009WO2008109465A4 Nucleic acid compounds for inhibiting fgfr gene expression and uses thereof
02/26/2009WO2008109372A3 Nucleic acid compounds for inhibiting pdgf gene expression and uses thereof
02/26/2009WO2008098199A3 Sequences for fk228 biosyntnesis and methods of synthesizing fk228 and fk228 analogs
02/26/2009WO2008091531A3 Elements for improved expression of bovine somatotropin
02/26/2009WO2008089144A3 Improved dna vaccination protocols
02/26/2009WO2008082429A3 Plant-specific genetic elements and transfer cassettes for plant transformation
02/26/2009WO2008073921A3 Mir-126 regulated genes and pathways as targets for therapeutic intervention
02/26/2009WO2008073920A3 Mir-21 regulated genes and pathways as targets for therapeutic intervention
02/26/2009WO2008073919A3 Mir-20 regulated genes and pathways as targets for therapeutic intervention
02/26/2009WO2008059041A3 Complementation of factor xi deficiency by factor v mutants
02/26/2009WO2008059009A3 Factor v mutants for hemostasis in hemophilia
02/26/2009WO2008045576A3 Compositions and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases
02/26/2009WO2005118866A9 COMPOSITIONS AND METHODS FOR SYNTHESIZING cDNA
02/26/2009WO2005116260A3 Influenza hemagglutinin and neuraminidase variants
02/26/2009US20090055976 Methods for the production of plants resistant to HPPD herbicides
02/26/2009US20090055975 Plant virus transmission inhibitor and methods
02/26/2009US20090055974 Nucleic acids and proteins associated with sucrose accumulation in coffee
02/26/2009US20090055973 Novel Omega-3 Fatty Acid Desaturase Family Members and Uses Thereof
02/26/2009US20090055972 Glutathione-s-transferase gene from proposis juliflora confers abiotic stress tolerance in plants
02/26/2009US20090055971 Plant having enhanced root elongation and method for production thereof
02/26/2009US20090055970 Yield increase in plants overexpressing the hsrp genes
02/26/2009US20090055969 Bacillus thuringiensis; conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds; controlling beetles; vectors, host cells
02/26/2009US20090055968 Method for producing direct in vitro flowering and viable seed from cotyledon, radicle, and leaf explants, and plants produced therefrom
02/26/2009US20090055967 Polynucleotides and polypeptides involved in post-transcriptional gene silencing
02/26/2009US20090055966 Maize Promoter Active in Silk and Pericarp Tissues
02/26/2009US20090055965 Increasing grain yield through targeted reduction in ethylene signaling
02/26/2009US20090055964 Mpo1 gene and protein and methods of use
02/26/2009US20090055963 Systemic gene silencing in plants
02/26/2009US20090055960 Soybean Cultivar 6540220
02/26/2009US20090055959 Soybean Cultivar S060292
02/26/2009US20090055958 Soybean Cultivar S050228
02/26/2009US20090055957 Soybean variety d4325666
02/26/2009US20090055956 Soybean variety d4125897
02/26/2009US20090055955 Soybean variety d4698573
02/26/2009US20090055954 Cotton variety 05z629
02/26/2009US20090055953 Cotton variety 05y063
02/26/2009US20090055952 Cotton variety 05x460
02/26/2009US20090055951 Cotton variety 04w019
02/26/2009US20090055950 Cotton variety 04t048
02/26/2009US20090055949 Cotton variety 03y062
02/26/2009US20090055948 Cotton variety 03y056
02/26/2009US20090055947 Cotton variety 03y047
02/26/2009US20090055945 Method for Producing Nuclear-Transplanted Egg
02/26/2009US20090055944 Human monoclonal antibodies to be programmed death ligand 1 (pd-l1)
02/26/2009US20090055943 Methods of modifying eukaryotic cells
02/26/2009US20090055942 Human Coagulation Factor VII Polypeptides
02/26/2009US20090055941 Novel Neural Cell Specific Promoter And Baculovirus And Method For Gene Delivery
02/26/2009US20090055940 Zebrafish model of mll leukemogenesis
02/26/2009US20090055100 Method for identifying and/or characterizing a (poly)peptide
02/26/2009US20090054954 Optical depolarization of cardiac tissue
02/26/2009US20090054625 Recombinant protein variants
02/26/2009US20090054624 useful in the treatment of a condition which is responsive to the PRO polypeptide, an agonist or antagonist thereof or an anti-PRO antibody
02/26/2009US20090054605 including a head assembly having an array of nozzles each coupled to a reservoir of liquid reagent and a base assembly having an array of reaction wells
02/26/2009US20090054367 Mycobacterial antigens expressed under low oxygen tension
02/26/2009US20090054366 RNAi MEDIATED KNOCKDOWN OF NUMA FOR CANCER THERAPY
02/26/2009US20090054365 RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF OCULAR NEOVASCULARIZATION
02/26/2009US20090054364 treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol
02/26/2009US20090054362 Compounds
02/26/2009US20090054358 Flt3 inhibitors for immune suppression
02/26/2009US20090054337 Natriuretic polypeptides
02/26/2009US20090054336 Binding Agent
02/26/2009US20090054328 Reagents and Methods for Modulating Gene Expression Related to Hypertension
02/26/2009US20090054327 Human immunodeficiency virus transactivator protein (HIV-TAT)-utrophin fusion for use in treatment of muscular disorders
02/26/2009US20090054325 Compositions and methods for suppressing axonal growth inhibition
02/26/2009US20090054324 Transcriptional Regulation of High Affitnity Ige Receptor Gamma-Chain
02/26/2009US20090054323 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT
02/26/2009US20090054321 Polypeptides and use thereof
02/26/2009US20090054320 Vesiculins
02/26/2009US20090054300 Using protein profiles aspredictive tools in prognosis and treatment of immune related disorders
02/26/2009US20090054263 Grating waveguide structure for multi-analyte determinations and the use thereof
02/26/2009US20090054257 Method of improving t cell receptors
02/26/2009US20090054252 Hemopexin-Like Structure as New Polypeptide-Scaffold
02/26/2009US20090054250 Methods to create fluorescent biosensors using aptamers with fluorescent base analogs
02/26/2009US20090054248 Connexin 40 tissue specific gene mutations
02/26/2009US20090054247 Polynucleotides encoding proteins involved in plant metabolism
02/26/2009US20090054244 Nucleic acid molecule encoding a novel estrogen receptor beta variant
02/26/2009US20090053813 Multiplexed electroporation apparatus
02/26/2009US20090053808 Compositions and methods for inhibiting the expression of anti-apoptopic genes
02/26/2009US20090053805 Post-partum mammalian placenta, its use and placental stem cells therefrom
02/26/2009US20090053802 Multipotent stem cells from peripheral tissues and uses thereof
02/26/2009US20090053795 Biocatalyst for use in chemical reactions associated with hydrolysis of triglycerides, esterfication and ester interchange; food processing; lipoproteins
02/26/2009US20090053794 improving production of amino acids, in particular L-lysine, L-tryptophan, L-proline, L-valine, L-isoleucine and L-homoserine; fermenting an isolated coryneform bacterium harboring a nucleic acid encoding an amino acid sequence comprising a a polypeptide having GTP-pyrophosphate kinase enzyme activity
02/26/2009US20090053791 Methods and composition for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs